Medical Isotope
Radiopharmaceuticals
GMP & GLP Solutions
Cancer Diagnosis & Treatment
About us
Careers
News & Events
Company News Industry Information
Contact
Language
EN CN
Home · News & Events

Industry Information

ASCO 2025: Phase 2 Trial of Re-Treatment with 177Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration Resistant Prostate Cancer (RE-LuPSMA Trial)

View more
Jun 06, 2025

ASCO 2025: Plasma Epigenomic Profiling to Reveal Molecular Correlates of Response and Resistance to 177Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer

View more
Jun 06, 2025

Radium-223 safety confirmed in long-term study

View more
Jun 06, 2025

New theranostics PET tracer shows promise

View more
Apr 18, 2025

PET/CT visualizes extremely rare brain inflammation

View more
Apr 02, 2025

GE HealthCare to Acquire Remaining 50% Stake in Nihon Medi-Physics (NMP), a Leading Radiopharmaceutical Company in Japan, from Sumitomo Chemical

View more
Dec 12, 2024
1234567...